Class information for:
Level 1: RAGE//RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS//SRAGE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5850 1568 44.4 92%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
648 3       ADVANCED GLYCATION END PRODUCTS//HMGB1//METHYLGLYOXAL 11882
1179 2             ADVANCED GLYCATION END PRODUCTS//METHYLGLYOXAL//GLYCATION 9308
5850 1                   RAGE//RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS//SRAGE 1568

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RAGE authKW 2626964 21% 41% 331
2 RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS authKW 1805706 11% 54% 172
3 SRAGE authKW 1216030 6% 71% 88
4 SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS authKW 854637 3% 83% 53
5 SOLUBLE RAGE authKW 519796 2% 86% 31
6 BIOCHEM MOL VASC BIOL address 468178 3% 52% 46
7 PATHOPHYSIOL THER EUT DIABET VASC COMPLIC address 444006 4% 35% 66
8 RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RAGE authKW 382334 2% 55% 36
9 ESRAGE authKW 373358 1% 91% 21
10 ADVANCED GLYCATION END PRODUCTS authKW 321585 11% 10% 166

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Endocrinology & Metabolism 1804 14% 0% 220
2 Medicine, Research & Experimental 952 10% 0% 160
3 Peripheral Vascular Diseases 775 7% 0% 113
4 Biochemistry & Molecular Biology 658 21% 0% 325
5 Cell Biology 511 11% 0% 174
6 Cardiac & Cardiovascular System 361 7% 0% 113
7 Respiratory System 337 4% 0% 69
8 Medical Laboratory Technology 169 2% 0% 31
9 Pharmacology & Pharmacy 129 8% 0% 125
10 Neurosciences 118 8% 0% 121

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BIOCHEM MOL VASC BIOL 468178 3% 52% 46
2 PATHOPHYSIOL THER EUT DIABET VASC COMPLIC 444006 4% 35% 66
3 PATHOPHYSIOL SCI 140132 3% 17% 42
4 DIABET PROGRAM ENDOCRINOL 124620 1% 80% 8
5 MED CLIN CHEM 1 66533 1% 16% 21
6 LIFE PHARM 53917 0% 46% 6
7 INTER MOL MED CIRMC 50209 0% 37% 7
8 RADIOISOTOPE BASIC CLIN MED 44438 1% 21% 11
9 PATHOPHYSIOL THER EUT DIABET VASC 43811 0% 75% 3
10 BIOL VASC CELLULAIRE 41228 0% 35% 6

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DIABETES 1412 2% 0% 30
2 ATHEROSCLEROSIS 1016 2% 0% 24
3 CARDIOVASCULAR DIABETOLOGY 993 1% 1% 8
4 DIABETES-METABOLISM RESEARCH AND REVIEWS 854 1% 1% 8
5 CURRENT MOLECULAR MEDICINE 817 0% 1% 7
6 CLINICAL BIOCHEMISTRY 720 1% 0% 14
7 EXPERIMENTAL DIABESITY RESEARCH 719 0% 4% 1
8 RESPIRATORY RESEARCH 684 1% 0% 8
9 JOURNAL OF DIABETES AND ITS COMPLICATIONS 677 1% 0% 8
10 DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH 661 1% 0% 8

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 RAGE 2626964 21% 41% 331 Search RAGE Search RAGE
2 RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS 1805706 11% 54% 172 Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS
3 SRAGE 1216030 6% 71% 88 Search SRAGE Search SRAGE
4 SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS 854637 3% 83% 53 Search SOLUBLE+RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS Search SOLUBLE+RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS
5 SOLUBLE RAGE 519796 2% 86% 31 Search SOLUBLE+RAGE Search SOLUBLE+RAGE
6 RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RAGE 382334 2% 55% 36 Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS+RAGE Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS+RAGE
7 ESRAGE 373358 1% 91% 21 Search ESRAGE Search ESRAGE
8 ADVANCED GLYCATION END PRODUCTS 321585 11% 10% 166 Search ADVANCED+GLYCATION+END+PRODUCTS Search ADVANCED+GLYCATION+END+PRODUCTS
9 AGES 292892 5% 19% 81 Search AGES Search AGES
10 ENDOGENOUS SECRETORY RAGE 119267 0% 88% 7 Search ENDOGENOUS+SECRETORY+RAGE Search ENDOGENOUS+SECRETORY+RAGE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 KALEA, AZ , SCHMIDT, AM , HUDSON, BI , (2009) RAGE: A NOVEL BIOLOGICAL AND GENETIC MARKER FOR VASCULAR DISEASE.CLINICAL SCIENCE. VOL. 116. ISSUE 7-8. P. 621-637 94 78% 74
2 XIE, JL , MENDEZ, JD , MENDEZ-VALENZUELA, V , AGUILAR-HERNANDEZ, MM , (2013) CELLULAR SIGNALLING OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE).CELLULAR SIGNALLING. VOL. 25. ISSUE 11. P. 2185-2197 96 53% 95
3 KIERDORF, K , FRITZ, G , (2013) RAGE REGULATION AND SIGNALING IN INFLAMMATION AND BEYOND.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 94. ISSUE 1. P. 55-68 93 56% 47
4 RAMASAMY, R , SHEKHTMAN, A , SCHMIDT, AM , (2016) THE MULTIPLE FACES OF RAGE - OPPORTUNITIES FOR THERAPEUTIC INTERVENTION IN AGING AND CHRONIC DISEASE.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 20. ISSUE 4. P. 431 -446 90 67% 0
5 RAMASAMY, R , YAN, SF , SCHMIDT, AM , (2011) RECEPTOR FOR AGE (RAGE): SIGNALING MECHANISMS IN THE PATHOGENESIS OF DIABETES AND ITS COMPLICATIONS.YEAR IN DIABETES AND OBESITY. VOL. 1243. ISSUE . P. 88-102 69 66% 122
6 YAN, SF , RAMASAMY, R , SCHMIDT, AM , (2010) SOLUBLE RAGE: THERAPY AND BIOMARKER IN UNRAVELING THE RAGE AXIS IN CHRONIC DISEASE AND AGING.BIOCHEMICAL PHARMACOLOGY. VOL. 79. ISSUE 10. P. 1379-1386 68 81% 59
7 SANTILLI, F , VAZZANA, N , BUCCIARELLI, LG , DAVI, G , (2009) SOLUBLE FORMS OF RAGE IN HUMAN DISEASES: CLINICAL AND THERAPEUTICAL IMPLICATIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 8. P. 940-952 74 69% 82
8 KALEA, AZ , SCHMIDT, AM , HUDSON, BI , (2011) ALTERNATIVE SPLICING OF RAGE: ROLES IN BIOLOGY AND DISEASE.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 16. ISSUE . P. 2756-2770 72 72% 32
9 SCHMIDT, AM , (2015) SOLUBLE RAGES - PROSPECTS FOR TREATING & TRACKING METABOLIC AND INFLAMMATORY DISEASE.VASCULAR PHARMACOLOGY. VOL. 72. ISSUE . P. 1 -8 54 84% 7
10 YAN, SF , RAMASAMY, R , SCHMIDT, AM , (2009) RECEPTOR FOR AGE (RAGE) AND ITS LIGANDS-CAST INTO LEADING ROLES IN DIABETES AND THE INFLAMMATORY RESPONSE.JOURNAL OF MOLECULAR MEDICINE-JMM. VOL. 87. ISSUE 3. P. 235 -247 74 63% 97

Classes with closest relation at Level 1


Rank Class id link
1 282 ADVANCED GLYCATION END PRODUCTS//GLYCATION//PENTOSIDINE
2 4116 HMGB1//HIGH MOBILITY GROUP BOX 1//HIGH MOBILITY GROUP BOX 1 PROTEIN
3 10755 S100A9//S100A8//CALPROTECTIN
4 16123 PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF
5 3263 S100A4//S100P//S100A6
6 7166 METHYLGLYOXAL//GLYOXALASE I//GLYOXALASE
7 20077 DIABETIC NEPHROPATHY//URINE CYTOKINES CHEMOKINES//TNF SYSTEM
8 4577 DIABETIC RETINOPATHY//K GE EYE//OPHTHALMOL
9 20109 ADVANCED OXIDATION PROTEIN PRODUCTS//MERCAPTALBUMIN//AOPPS
10 27625 METABOLIC MEMORY//IL RISK ASSESSMENT INTERVENT STUDIES//HYPERGLYCEMIC MEMORY

Go to start page